Leadership Overview
Westat has 6 executives leading key functions including strategy, technology, information systems, finance, and operations.
Driven by a commitment to data-driven insights, Westat provides professional services to government agencies, businesses, and local governments, focusing on survey research, study design, analytics, and data collection to inform critical decisions.
Driven by a commitment to data-driven insights, Westat provides professional services to government agencies, businesses, and local governments, focusing on survey research, study design, analytics, and data collection to inform critical decisions.
Leadership Roles at Westat
Daniel Gilden - President & Chief Executive Officer
Daniel Gilden, the President & Chief Executive Officer at Westat, directs the company's overall strategic vision and operational execution. Gilden oversees all business units, ensuring alignment with the company's mission to provide high-quality research and analytical services. This leadership role involves driving growth initiatives and fostering innovation across the organization. By focusing on client needs and market trends, Daniel Gilden ensures Westat maintains its position as a trusted partner for government agencies, businesses, and local governments. The Chief Executive Officer's purview extends to financial performance, resource allocation, and long-term sustainability, guaranteeing the company's continued success in survey research, study design, analytics, and data collection.
Scott Royal - President & Chief Executive Officer
Scott Royal, the President & Chief Executive Officer at Westat, guides the company's strategic direction and operational framework. Royal is responsible for the comprehensive management of Westat's service offerings, including survey research, study design, analytics, and data collection. This executive position involves cultivating strong relationships with key stakeholders and government agencies to expand market reach. By championing operational excellence, Scott Royal ensures the delivery of impactful solutions that address complex societal and business challenges. The Chief Executive Officer's leadership ensures robust financial health and strategic growth, solidifying Westat's reputation for integrity and expertise in research services.
Oswaldo Holguin - Senior Vice President & Chief Financial Officer
Oswaldo Holguin, the Senior Vice President & Chief Financial Officer at Westat, directs the company's financial strategy and fiscal management. Holguin oversees all financial operations, including budgeting, forecasting, and financial reporting, critical for Westat's service delivery to government agencies and businesses. This executive role involves managing capital resources and ensuring financial compliance across all projects, from survey research to complex data analytics. By maintaining strong financial controls and optimizing resource allocation, Oswaldo Holguin supports the company's sustainable growth and operational efficiency. The Chief Financial Officer's expertise ensures the financial integrity of Westat's operations, underpinning its ability to undertake large-scale study designs and data collection initiatives.
Olubusola Afolabi - President
Olubusola Afolabi, the President at Westat, drives strategic initiatives and operational oversight for key business segments. Afolabi focuses on enhancing Westat's service portfolio, which includes advanced survey research, meticulous study design, and comprehensive data collection services for government and commercial clients. This leadership position involves fostering cross-functional collaboration to ensure the successful execution of complex projects. By championing client-centric solutions, Olubusola Afolabi strengthens Westat's market presence and reputation for delivering high-impact analytical insights. The President's role is integral to maintaining operational excellence and advancing the company's mission in providing critical research and data services.
Christopher Coulthard - Chief Technology Officer
Christopher Coulthard, the Chief Technology Officer at Westat, architects the company's technological infrastructure and innovation roadmap. Coulthard directs the development and implementation of advanced data collection platforms and analytical tools, crucial for Westat's survey research and study design services. This role involves evaluating emerging technologies to enhance data integrity and processing efficiency. By ensuring robust cybersecurity measures and scalable IT solutions, Christopher Coulthard supports the secure handling of sensitive data for government agencies and businesses. The Chief Technology Officer's strategic oversight ensures that Westat's technological capabilities remain at the forefront, enabling sophisticated analytics and data-driven insights for clients nationwide.
Dwight Feanny - Vice President & Chief Information Officer
Dwight Feanny, the Vice President & Chief Information Officer at Westat, manages the company's information systems and digital resources. Feanny oversees the integration of technology solutions that support Westat's core operations in survey research, study design, and data collection. This leadership position involves ensuring the reliability, security, and efficiency of all IT infrastructure across the organization. By optimizing data management systems and network operations, Dwight Feanny enhances the company's capacity to deliver complex analytical services. The Chief Information Officer's focus on technological advancement ensures seamless data flow and robust support for Westat's diverse client base, including government entities and private businesses.
Explore Leadership Teams in Business Services
PAREXEL International Corporation, a biopharmaceutical outsourcing services company, provides clinical research and logistics, medical communications, consulting, commercialization, and advanced technology products and services for pharmaceutical, biotechnology, and medical device industries worldwide. The company operates in three segments: Clinical Research Services (CRS), PAREXEL Consulting Services (PC), and PAREXEL Informatics (PI). The CRS segment offers clinical trials management, observational studies, patient/disease registries and post-marketing surveillance, data management, and biostatistical analysis, epidemiology and health economics/outcomes research, clinical supply and drug logistics, pharmacovigilance, commercialization, and clinical pharmacology, as well as related medical affairs, patient recruitment, and investigator site services. The PC segment provides technical expertise and advice in various areas, such as drug development, regulatory affairs, product pricing and reimbursement, commercialization, and strategic compliance; and market and product development, and targeted communications services to support product launch, as well as offers solutions to address client issues associated with product development, registration, and commercialization. The PI segment provides information technology solutions comprising ClinPhone randomization and trial supply management solutions, medical imaging services, IMPACT clinical trial management systems, LIQUENT InSight regulatory information management software and professional services, DataLabs electronic data capture systems, Web-based portals, systems integration services, electronic patient reported outcomes, and patient diary applications, as well as centralized assessment services for patient technology solutions. PAREXEL International Corporation was founded in 1983 and is headquartered in Waltham,...
Company Leadership
DT
Discovery Life Sciences is the global market leader in biospecimen analysis, procurement, distribution, and scientific services for the pharmaceutical, biotechnology, and diagnostics industries. HudsonAlpha Discovery is Discovery's globally recognized sequencing and bioinformatics division that leverages the most current genomic research technologies to comprehensively support discovery, translational, and clinical research. Driven by science, the Discovery team engages with customers in an innovative, consultative approach to overcoming obstacles and reaching a faster end result. Discovery Life Sciences is headquartered in Huntsville, Alabama.
Company Leadership GH
SH
Founded in 1981 and headquartered in Waltham, Massachusetts, Repligen is a bioprocessing-focused life sciences company that is inspiring advances in bioprocessing through the development and commercialization of high-value products and flexible solutions that address critical steps in the production of biologic drugs.
Company Leadership OL
JB
KL
As a global Contract Research Organization Laboratory (CRO) to the biopharmaceutical industry, CellCarta provides access to a broad offering of biomarker platforms and services. We partner with you to address the most complex scientific testing needs, delivering customized biomarker testing solutions to further the limitless potential of precision medicine.
Company Leadership DT
AM
EM
Frequently Asked Questions Regarding Westat Top Executives and Leadership Team
